Cell senescence in liver diseases: pathological mechanism and theranostic opportunity
The DOI matches its Crossref record; 186 of the 187 references it cites were found in a registry or an index.
Abstract
The liver is not oblivious to the passage of time, as ageing is a major risk factor for the development of acute and chronic liver diseases. Ageing produces alterations in all hepatic cells, affecting their phenotype and function and worsening the prognosis of liver disease. The ageing process also implies the accumulation of a cellular state characterized by a persistent proliferation arrest and a specific secretory phenotype named cellular senescence. Indeed, senescent cells have key roles in many physiological processes; however, their accumulation owing to ageing or pathological conditions contributes to the damage occurring in chronic diseases. The aim of this Review is to provide an updated description of the pathophysiological events in which hepatic senescent cells are involved and their role in liver disease progression. Finally, we discuss novel geroscience therapies that could be applied to prevent or improve liver diseases and age-mediated hepatic deregulations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cellular senescence, a stress-induced program causing stable cell-cycle arrest, is a hallmark of liver aging, fibrosis, and cancer.”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [3]
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 1×
“This type of cancer is primarily associated with risk factors such as HBC and HCV infections, excessive alcohol consumption and obesity, which substantially contribute to its pathogenesis 136 .”
The serial cultivation of human diploid cell strains
Hayflick, L., & Moorhead, P. S. (1961) · Experimental Cell Research · doi:10.1016/0014-4827(61)90192-6 · Cited by 8,508
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477 · cited 5×
“Conversely, HSCs lacking functional p53 secrete specific factors that facilitate the polarization of macrophages towards a tumour-promoting phenotype through the secretion of IL-33, therefore enhancing the proliferation of premalignant cells 93–95 .”
InfluentialHallmarks of aging: An expanding universe
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2023) · Cell · doi:10.1016/j.cell.2022.11.001 · Cited by 6,549 · cited 1×
“…of TP53 (coding for p53) and different cyclin-dependent kinase (CDK) inhibitors, such as p16 and p21, which results in persistent activation of the retinoblastoma family proteins and the inhibition of transcriptional activators (E2F family) that are required for cell cycle progression 19,20 .”
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 3×
“As described above, SASP encompasses a multitude of factors released by senescent cells, including cytokines, chemokines, interleukins and growth factors, such as IL-1, IL-6, C-C motif chemokine ligand 2 (CCL2) and insulin-like growth factor, among others 24 .”
Extension of Life-Span by Introduction of Telomerase into Normal Human Cells
Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C.-P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., & Wright, W. E. (1998) · Science · doi:10.1126/science.279.5349.349 · Cited by 4,975
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Cellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 6×
“Certainly, within the spectrum delineated by these two contrasting conditions, actively dividing cells can transition into alternative states, including cellular senescence 1 .”
InfluentialMechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · cited 1×
“Notably, this contradicts what is observed during liver dysfunction, in which the loss of lipid droplets is a characteristic of HSC activation 89 .”
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818 · cited 4×
“…of MASLD in HFD-fed mice through the hepatic accumulation of so-called albumosomes — spherical shell-like structures in the cytoplasm formed by prefolding albumin — which can trap prefolding carnitine palmi-toyltransferase 2 thereby maintaining mitochondrial homeostasis from exhaustion 149 .”
InfluentialThe Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Zhu, Y., Tchkonia, T., Pirtskhalava, T., Gower, A. C., Ding, H., Giorgadze, N., Palmer, A. K., Ikeno, Y., Hubbard, G. B., Lenburg, M., et al. (2015) · Aging Cell · doi:10.1111/acel.12344 · Cited by 2,584 · cited 1×
“The first senolytics identified were a combination of dasatinib and quercetin, discovered through a hypothesis-driven, bioinformatics-based investigation 141 .”
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473 · cited 2×
“Regarding senescence induction in HCC, the in vivo therapeutic activation of p53 was capable of stunting tumour growth, firstly by inducing cell cycle arrest and secondly by promoting the secretion of inflammatory cytokines that signal the immune response to clear tumoural-senescent cells 27 .”
A complex secretory program orchestrated by the inflammasome controls paracrine senescence
Acosta, J. C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J. P., Athineos, D., Kang, T.-W., Lasitschka, F., Andrulis, M., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2784 · Cited by 2,278
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277 · cited 1×
“process, such as DNA damage, cellular stress inducers and oncogene activation 2,15 .”
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
Yoshimoto, S., Loo, T. M., Atarashi, K., Kanda, H., Sato, S., Oyadomari, S., Iwakura, Y., Oshima, K., Morita, H., Hattori, M., et al. (2013) · Nature · doi:10.1038/nature12347 · Cited by 2,219 · cited 3×
“111).”
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027 · cited 6×
“FOXO4–D-retroinverso (FOXO4-DRI) is a peptide with senolytic activity, capable of interfering with the FOXO4– TP53 interaction, allowing p53 to translocate to the cytosol and induce apoptosis 146 .”
InfluentialSenescence in Health and Disease
He, S., & Sharpless, N. E. (2017) · Cell · doi:10.1016/j.cell.2017.05.015 · Cited by 1,766 · cited 3×
“In the context of persistent insults, cells undergoing damage exhibit a heightened susceptibility to entering a senescent state, as evidenced in numerous chronic diseases in preclinical and clinical studies 18 .”
Ginès, P., Krag, A., Abraldes, J. G., Solà, E., Fabrellas, N., & Kamath, P. S. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01374-x · Cited by 1,663
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Kang, T.-W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., et al. (2011) · Nature · doi:10.1038/nature10599 · Cited by 1,621 · cited 5×
“However, the malfunctioning or escape of this senescent surveillance can result in the survival of these cells, which can further replicate leading to the development of HCC 53,54 .”
InfluentialBaar, M. P., Brandt, R. M. C., Putavet, D. A., Klein, J. D. D., Derks, K. W. J., Bourgeois, B. R. M., Stryeck, S., Rijksen, Y., van Willigenburg, H., Feijtel, D. A., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.031 · Cited by 1,454 · cited 2×
“This peptide was able to counteract chemotherapy-induced senescence and the associated weight loss and liver toxicity in mice 146 .”
Senescence-associated β-galactosidase is lysosomal β-galactosidase.
Lee, B. Y., Han, J. A., Im, J. S., Morrone, A., Johung, K., Goodwin, E. C., Kleijer, W. J., DiMaio, D., & Hwang, E. S. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00199.x · Cited by 1,444 · cited 7×
“The number and size of lysosomes in senescent cells increase 32 , and this feature has been associated with the accumulation of senescence-associated β-galactosidase (SA-β-gal).”
InfluentialL1 drives IFN in senescent cells and promotes age-associated inflammation
De Cecco, M., Ito, T., Petrashen, A. P., Elias, A. E., Skvir, N. J., Criscione, S. W., Caligiana, A., Brocculi, G., Adney, E. M., Boeke, J. D., et al. (2019) · Nature · doi:10.1038/s41586-018-0784-9 · Cited by 1,255 · cited 1×
“…of proteasomal degradation of histone methyltransferases, such as G9a and GLP, through the activation of APC/C Cdh1 ubiquitin ligase 28 , the upregulation of LINE-1 elements 29 , and the transcription of stimulator of interferon genes (STING), which promotes the production of SASP factors 30 .”
Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence
Glück, S., Guey, B., Gulen, M. F., Wolter, K., Kang, T.-W., Schmacke, N. A., Bridgeman, A., Rehwinkel, J., Zender, L., & Ablasser, A. (2017) · Nature Cell Biology · doi:10.1038/ncb3586 · Cited by 1,196 · cited 1×
“…of proteasomal degradation of histone methyltransferases, such as G9a and GLP, through the activation of APC/C Cdh1 ubiquitin ligase 28 , the upregulation of LINE-1 elements 29 , and the transcription of stimulator of interferon genes (STING), which promotes the production of SASP factors 30 .”
Cellular senescence: the good, the bad and the unknown
Huang, W., Hickson, L. J., Eirin, A., Kirkland, J. L., & Lerman, L. O. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00601-z · Cited by 1,150 · cited 1×
“However, prolonged and accumulated senescence results in detrimental consequences, leading to tumour development, chronic inflammation, immune deficit and stem cell exhaustion 16 .”
Zhu, Y., Tchkonia, T., Fuhrmann‐Stroissnigg, H., Dai, H. M., Ling, Y. Y., Stout, M. B., Pirtskhalava, T., Giorgadze, N., Johnson, K. O., Giles, C. B., et al. (2016) · Aging Cell · doi:10.1111/acel.12445 · Cited by 1,148 · cited 1×
“Navitoclax (also known as ABT-263) is an inhibitor of anti-apoptotic proteins belonging to the BCL2 family that induces apoptosis and exhibits potent senolytic effects in ageing animal models and in certain types of senescence in vitro 143 .”
Cellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134 · cited 1×
“…to the intermittent administration of senolytics, which proves effective, the beneficial effects of senom-orphics might necessitate regular and prolonged usage, which could potentially give rise to unforeseen adverse effects and induce off-target effects by suppressing cytokine secretion 151 .”
cGAS–STING drives ageing-related inflammation and neurodegeneration
Gulen, M. F., Samson, N., Keller, A., Schwabenland, M., Liu, C., Glück, S., Thacker, V. V., Favre, L., Mangeat, B., Kroese, L. J., et al. (2023) · Nature · doi:10.1038/s41586-023-06373-1 · Cited by 1,104 · cited 1×
“Remarkably, STING inhibition in human tissue and fibroblasts, and in mice, has been associated with a decrease in the pro-inflammatory phenotype of senescent cells 31 .”
Senolytic CAR T cells reverse senescence-associated pathologies
Amor, C., Feucht, J., Leibold, J., Ho, Y.-J., Zhu, C., Alonso-Curbelo, D., Mansilla-Soto, J., Boyer, J. A., Li, X., Giavridis, T., et al. (2020) · Nature · doi:10.1038/s41586-020-2403-9 · Cited by 1,098 · cited 1×
“plasminogen activator receptor, attenuated senescence-associated diseases, including liver fibrosis 150 .”
Cellular senescence drives age-dependent hepatic steatosis
Ogrodnik, M., Miwa, S., Tchkonia, T., Tiniakos, D., Wilson, C. L., Lahat, A., Day, C. P., Burt, A., Palmer, A., Anstee, Q. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15691 · Cited by 1,044 · cited 3×
“In another preclinical study, when hepatocyte senescence was induced, it also promoted liver steatosis, whereas eliminating those senescent cells reduced lipid levels in the liver 120 .”
Unmasking Transcriptional Heterogeneity in Senescent Cells
Hernandez-Segura, A., de Jong, T. V., Melov, S., Guryev, V., Campisi, J., & Demaria, M. (2017) · Current Biology · doi:10.1016/j.cub.2017.07.033 · Cited by 972 · cited 2×
“Senescence is defined by a highly heterogeneous and complex phenotype, which can differ depending on the cellular type and the senescence inducer 17 .”
Exploiting senescence for the treatment of cancer
Wang, L., Lankhorst, L., & Bernards, R. (2022) · Nature Reviews Cancer · doi:10.1038/s41568-022-00450-9 · Cited by 867 · cited 1×
“Although tumoural cells have escaped senescence activation, studies have shown that they can still be induced, posing an attractive therapeutic approach for HCC treatment 170 .”
Role of Kupffer cells in host defense and liver disease
Bilzer, M., Roggel, F., & Gerbes, A. L. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01342.x · Cited by 856 · cited 1×
“Kupffer cells represent between 80% and 90% of the liver-resident macrophages and are located in the lumen of the hepatic sinusoid 99 .”
Cellular senescence and its effector programs
Salama, R., Sadaie, M., Hoare, M., & Narita, M. (2014) · Genes & Development · doi:10.1101/gad.235184.113 · Cited by 855
Non-Cell-Autonomous Tumor Suppression by p53
Lujambio, A., Akkari, L., Simon, J., Grace, D., Tschaharganeh, D. F., Bolden, J. E., Zhao, Z., Thapar, V., Joyce, J. A., Krizhanovsky, V., et al. (2013) · Cell · doi:10.1016/j.cell.2013.03.020 · Cited by 766 · cited 3×
“Senescent HSCs also acquire a pro-inflammatory phenotype, promoting immune surveillance 93 .”
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766 · cited 1×
“…of protein kinase AMP-activated catalytic subunit-ɑ (AMPK), which inhibits the mammalian target of rapamycin complex 1 and induces peroxisome proliferator-activated receptor-γ coactivator 1-ɑ , together with reduction in ROS production, and inhibition of pro-inflammatory cytokine signalling 153 .”
A senescent cell bystander effect: senescence‐induced senescence
Nelson, G., Wordsworth, J., Wang, C., Jurk, D., Lawless, C., Martin‐Ruiz, C., & von Zglinicki, T. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00795.x · Cited by 755
Telomere dysfunction in ageing and age-related diseases
Rossiello, F., Jurk, D., Passos, J. F., & d’Adda di Fagagna, F. (2022) · Nature Cell Biology · doi:10.1038/s41556-022-00842-x · Cited by 754
Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c
Poynard, T., Ratziu, V., Charlotte, F., Goodman, Z., McHutchison, J., & Albrecht, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00097-0 · Cited by 749 · cited 1×
“The prevalence of ALD and its complications also increase with age 182 , as well as the progression and complications related to hepatitis B and C infection 183,184 .”
The Epidemiology of Nonalcoholic Fatty Liver Disease: A Global Perspective
Lazo, M., & Clark, J. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091978 · Cited by 736
Pimpin, L., Cortez-Pinto, H., Negro, F., Corbould, E., Lazarus, J. V., Webber, L., & Sheron, N. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.011 · Cited by 710
Identification of HSP90 inhibitors as a novel class of senolytics
Fuhrmann-Stroissnigg, H., Ling, Y. Y., Zhao, J., McGowan, S. J., Zhu, Y., Brooks, R. W., Grassi, D., Gregg, S. Q., Stripay, J. L., Dorronsoro, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00314-z · Cited by 701 · cited 1×
“Heat shock protein 90 (HSP90) inhibitors have also demonstrated senolytic activity 147 .”
Zhang, R., Poustovoitov, M. V., Ye, X., Santos, H. A., Chen, W., Daganzo, S. M., Erzberger, J. P., Serebriiskii, I. G., Canutescu, A. A., Dunbrack, R. L., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2004.10.019 · Cited by 699 · cited 1×
“…changes, becoming flattened and enlarged, with dramatic changes in chromatin structure that can be visualized as associated heterochromatin foci 21 ; however, they seem to be cell type-dependent and stimulus-dependent as they are not present in all senescent cells, such as mouse fibroblasts,…”
Moiseeva, O., Deschênes‐Simard, X., St‐Germain, E., Igelmann, S., Huot, G., Cadar, A. E., Bourdeau, V., Pollak, M. N., & Ferbeyre, G. (2013) · Aging Cell · doi:10.1111/acel.12075 · Cited by 654 · cited 1×
“In addition, treatment of senescent cells with metformin disrupted support for cancerous cell growth caused by factors secreted by senescent cells through blockade of the NF-κB transcription factor 152 .”
Dixon, L. J., Barnes, M., Tang, H., Pritchard, M. T., & Nagy, L. E. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120026 · Cited by 628 · cited 1×
“The Kupffer cell pro-inflammatory response initially offers protective mechanisms to the damaged liver but, when sustained over time, switches towards a damaging response that further aggravates liver disease 100 .”
Targeting cellular senescence with senotherapeutics: senolytics and senomorphics
Zhang, L., Pitcher, L. E., Prahalad, V., Niedernhofer, L. J., & Robbins, P. D. (2023) · The FEBS Journal · doi:10.1111/febs.16350 · Cited by 621 · cited 1×
“Resveratrol is a polyphenol found in grapes, berries, peanuts and red wine, with reported anti-ageing effects 162 .”
Eggert, T., Wolter, K., Ji, J., Ma, C., Yevsa, T., Klotz, S., Medina-Echeverz, J., Longerich, T., Forgues, M., Reisinger, F., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.003 · Cited by 609 · cited 4×
“…senescent pro-oncogenic hepatocytes is dependent on Kupffer cells and macrophages; however, senescent hepatocytes, through the secretion of CCL2, recruit immature myeloid cells, which have an immunosuppressive phenotype that inhibits tumour and senescence clearance permitting the growth of HCC 53 .”
InfluentialResveratrol and health—A comprehensive review of human clinical trials
Smoliga, J. M., Baur, J. A., & Hausenblas, H. A. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100143 · Cited by 594 · cited 1×
“Also, other clinical and preclinical studies have found that resveratrol targets other parameters in the liver that are usually altered due to senescence, such as oxidative stress, mitochondrial dysfunction and lipid accumulation 164–166 .”
Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis
WIEMANN, S. U., SATYANARAYANA, A., TSAHURIDU, M., TILLMANN, H. L., ZENDER, L., KLEMPNAUER, J., FLEMMING, P., FRANCO, S., BLASCO, M. A., MANNS, M. P., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0977com · Cited by 527 · cited 2×
“In human cirrhosis; for instance, telomere shortening is more pronounced in hepatocytes rather than in HSCs 87 .”
Kim, I. H., Kisseleva, T., & Brenner, D. A. (2015) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000176 · Cited by 497
Mechanisms and consequences of endothelial cell senescence
Bloom, S. I., Islam, M. T., Lesniewski, L. A., & Donato, A. J. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00739-0 · Cited by 495 · cited 2×
“Endothelial cells, including LSECs, are constantly exposed to circulating blood that contains various substances capable of contributing to senescence, such as oxygen, glucose, lipids, amino acid metabolites, immune cells, ROS and inflammatory cytokines 77 .”
Age-related changes in liver structure and function: Implications for disease ?
Schmucker, D. L. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.06.009 · Cited by 481 · cited 12×
“Damaged livers from two cohorts of patients with ALD (one of 42 patients and one of 77 patients) exhibited a marked increase in the senescent hepatocyte population during advanced disease 44 , which indicates the important role of senescence during disease development.”
InfluentialLoo, T. M., Kamachi, F., Watanabe, Y., Yoshimoto, S., Kanda, H., Arai, Y., Nakajima-Takagi, Y., Iwama, A., Koga, T., Sugimoto, Y., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0932 · Cited by 478 · cited 1×
“…that certain molecules derived from the gut microbiota can enter the enterohepatic circulation, reaching the hepatic sinusoid, where they induce the senescence of HSCs, which, via the SASP, secrete pro-inflammatory cytokines and tumour-promoting factors that can promote HCC development 110,111 .”
Defined p16High Senescent Cell Types Are Indispensable for Mouse Healthspan
Grosse, L., Wagner, N., Emelyanov, A., Molina, C., Lacas-Gervais, S., Wagner, K.-D., & Bulavin, D. V. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.002 · Cited by 460 · cited 4×
“This notion was supported by the increased p16 gene expression in LSEC in ageing mice and rats 61,74 .”
InfluentialInterleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
Kong, X., Feng, D., Wang, H., Hong, F., Bertola, A., Wang, F.-S., & Gao, B. (2012) · Hepatology · doi:10.1002/hep.25744 · Cited by 448 · cited 3×
“Differently, induction of IL-22, which has been found to induce senescence of HSCs in mice 98 , might be an effective antifibrotic treatment 174–176 .”
Inducing and exploiting vulnerabilities for the treatment of liver cancer
Wang, C., Vegna, S., Jin, H., Benedict, B., Lieftink, C., Ramirez, C., de Oliveira, R. L., Morris, B., Gadiot, J., Wang, W., et al. (2019) · Nature · doi:10.1038/s41586-019-1607-3 · Cited by 427 · cited 1×
“…in an in vivo and in vitro study, the arrest of DNA replication via cell division cycle 7 inhibition, followed by treatment with the repurposed anti-depressant drug, sertraline, which effectively suppresses mTOR signalling, led to apoptosis induction and subsequent inhibition of tumour growth 171 .”
Inhibition of Experimental Liver Cirrhosis in Mice by Telomerase Gene Delivery
Rudolph, K. L., Chang, S., Millard, M., Schreiber-Agus, N., & DePinho, R. A. (2000) · Science · doi:10.1126/science.287.5456.1253 · Cited by 424 · cited 3×
“In this regard, in a mouse model deficient in telomerase specifically lacking the telomerase RNA gene, telomere dysfunction was associated with impairment in liver regeneration and an accelerated progression of liver cirrhosis following chronic liver injury 50 .”
InfluentialNK cell–mediated cytotoxicity contributes to tumor control by a cytostatic drug combination
Ruscetti, M., Leibold, J., Bott, M. J., Fennell, M., Kulick, A., Salgado, N. R., Chen, C.-C., Ho, Y.-J., Sanchez-Rivera, F. J., Feucht, J., et al. (2018) · Science · doi:10.1126/science.aas9090 · Cited by 415 · cited 1×
“Inducing controlled senescence in the tumoural site has also been shown as a promising therapeutic option, activating key pro-inflammatory cytokines and surface markers that activate natural killer cells that clear tumoural cells 172 .”
Role of liver sinusoidal endothelial cells in liver diseases
Gracia-Sancho, J., Caparrós, E., Fernández-Iglesias, A., & Francés, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00411-3 · Cited by 410 · cited 2×
“Senescence of LSECs leads to pseudocapillarization, reduced endocytic and vasodilatory capacity, decreased plasticity in blood flow, and increased production of mitochondrial oxidative stress 61,62,66,67 .”
Self-citationForrest, E. H., Evans, C. D. J., Stewart, S., Phillips, M., Oo, Y. H., McAvoy, N. C., Fisher, N. C., Singhal, S., Brind, A., Haydon, G., et al. (2005) · Gut · doi:10.1136/gut.2004.050781 · Cited by 390
Interplay between oncogene-induced DNA damage response and heterochromatin in senescence and cancer
Di Micco, R., Sulli, G., Dobreva, M., Liontos, M., Botrugno, O. A., Gargiulo, G., dal Zuffo, R., Matti, V., d'Ario, G., Montani, E., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2170 · Cited by 382 · cited 1×
“…21 ; however, they seem to be cell type-dependent and stimulus-dependent as they are not present in all senescent cells, such as mouse fibroblasts, as opposed to human fibroblasts 22 , or during replicative cellular senescence in human fibroblasts resistant to premature p16 INK4a activation 23 .”
C/EBPα Arrests Cell Proliferation through Direct Inhibition of Cdk2 and Cdk4
Wang, H., Iakova, P., Wilde, M., Welm, A., Goode, T., Roesler, W. J., & Timchenko, N. A. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00366-5 · Cited by 355 · cited 1×
“CEBPA is another transcriptional factor pivotal in liver function; it directly interacts with CDK2 and CDK4, inhibiting cell proliferation 56,57 .”
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease
Aravinthan, A., Scarpini, C., Tachtatzis, P., Verma, S., Penrhyn-Lowe, S., Harvey, R., Davies, S. E., Allison, M., Coleman, N., & Alexander, G. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.10.031 · Cited by 326 · cited 1×
“Moreover, in another study, hepatocytes from 70 patients with MASLD had shorter telomeres and higher gene expression levels of CDKN1A (coding for p21) than those from 60 healthy matched donor livers, which correlated with fibrosis stage and adverse liver-related outcomes 124 .”
Hepatic stellate cells in physiology and pathology
Kamm, D. R., & McCommis, K. S. (2022) · The Journal of Physiology · doi:10.1113/jp281061 · Cited by 325 · cited 1×
“This transformation is accompanied by cell proliferation, induction of inflammation and ECM remodelling, with activated HSCs becoming the primary source of ECM components in damaged liver tissues 90 .”
Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas
Paradis, V., Youssef, N., Dargère, D., Bâ, N., Bonvoust, F., Deschatrette, J., & Bedossa, P. (2001) · Human Pathology · doi:10.1053/hupa.2001.22747 · Cited by 314
Trebicka, J., Hennenberg, M., Laleman, W., Shelest, N., Biecker, E., Schepke, M., Nevens, F., Sauerbruch, T., & Heller, J. (2007) · Hepatology · doi:10.1002/hep.21673 · Cited by 305 · cited 1×
“In cirrhotic livers of rats, this effect was achieved by activating KLF2, leading to reduced HSC activation and decreased portal hypertension 156,157 .”
The Influence of Age and Sex on the Clearance of Cytochrome P450 3A Substrates
Cotreau, M. M., von Moltke, L. L., & Greenblatt, D. J. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00002 · Cited by 292
Gao, Y., Zhang, W., Zeng, L.-Q., Bai, H., Li, J., Zhou, J., Zhou, G.-Y., Fang, C.-W., Wang, F., & Qin, X.-J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101635 · Cited by 291 · cited 1×
“For instance, exercise and calorie restriction in a preclinical model of HFD-induced MASLD led to amelioration in liver senescence and steatosis as a result of an increase in liver lipophagy 159 .”
Hepatic microcirculation and mechanisms of portal hypertension
Gracia-Sancho, J., Marrone, G., & Fernández-Iglesias, A. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0097-3 · Cited by 274
Self-citationExercise Prevents Diet-Induced Cellular Senescence in Adipose Tissue
Schafer, M. J., White, T. A., Evans, G., Tonne, J. M., Verzosa, G. C., Stout, M. B., Mazula, D. L., Palmer, A. K., Baker, D. J., Jensen, M. D., et al. (2016) · Diabetes · doi:10.2337/db15-0291 · Cited by 267 · cited 1×
“Similar effects were obtained with moderate exercise in rats, with the researchers attributing these effects to an increase in NAD + levels in the liver 160 .”
Bird, T. G., Müller, M., Boulter, L., Vincent, D. F., Ridgway, R. A., Lopez-Guadamillas, E., Lu, W.-Y., Jamieson, T., Govaere, O., Campbell, A. D., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan1230 · Cited by 261 · cited 3×
“Liver-resident macrophages also participate in senescence spreading to bystander cells through TGFβ1 ligand 108 .”
InfluentialRobust, universal biomarker assay to detect senescent cells in biological specimens
Evangelou, K., Lougiakis, N., Rizou, S. V., Kotsinas, A., Kletsas, D., Muñoz‐Espín, D., Kastrinakis, N. G., Pouli, N., Marakos, P., Townsend, P., et al. (2017) · Aging Cell · doi:10.1111/acel.12545 · Cited by 259
A Spectrum of Severe Familial Liver Disorders Associate with Telomerase Mutations
Calado, R. T., Regal, J. A., Kleiner, D. E., Schrump, D. S., Peterson, N. R., Pons, V., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007926 · Cited by 254 · cited 1×
“In a clinical study in 69 patients with cirrhosis, loss-of-function mutations in the telomerase reverse transcriptase (TERT) and telomerase RNA component genes were found to be implicated in familial liver abnormalities 131 .”
Koehler, E. M., Schouten, J. N. L., Hansen, B. E., van Rooij, F. J. A., Hofman, A., Stricker, B. H., & Janssen, H. L. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.028 · Cited by 251 · cited 2×
“Clinical studies have shown that MASLD prevalence increases with age 7,181 being 16% higher in older patients than in younger ones, with the former having an increased risk of advanced fibrosis during MASH, among other features of severe damage 116 .”
InfluentialLiver diseases and aging: friends or foes?
Sheedfar, F., Biase, S. D., Koonen, D., & Vinciguerra, M. (2013) · Aging Cell · doi:10.1111/acel.12128 · Cited by 248 · cited 1×
“…in the liver, other alterations associated with age, such as insulin and leptin resistance, the decrease in growth hormone and adiponectin, hypercholesterolaemia, DNA damage, accumulation of ROS and telomere shortening, also contribute to a higher risk of MASLD in the older population 114,115 .”
Morphologic changes accompanying senescence of cultured human diploid cells
Robbins, E., Levine, E. M., & Eagle, H. (1970) · The Journal of Experimental Medicine · doi:10.1084/jem.131.6.1211 · Cited by 247 · cited 1×
“The number and size of lysosomes in senescent cells increase 32 , and this feature has been associated with the accumulation of senescence-associated β-galactosidase (SA-β-gal).”
The bystander effect contributes to the accumulation of senescent cells in vivo
da Silva, P. F. L., Ogrodnik, M., Kucheryavenko, O., Glibert, J., Miwa, S., Cameron, K., Ishaq, A., Saretzki, G., Nagaraja‐Grellscheid, S., Nelson, G., et al. (2019) · Aging Cell · doi:10.1111/acel.12848 · Cited by 247 · cited 1×
“Senescent hepatocytes have also been suggested to induce senescence of nearby cells through a process known as senescence ‐ induced bystander senescence, which is discussed in the section below ‘ Importance of SASP in hepatic paracrine communication’ 58,59 .”
Marrone, G., Russo, L., Rosado, E., Hide, D., García-Cardeña, G., García-Pagán, J. C., Bosch, J., & Gracia-Sancho, J. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.026 · Cited by 241 · cited 1×
“In cirrhotic livers of rats, this effect was achieved by activating KLF2, leading to reduced HSC activation and decreased portal hypertension 156,157 .”
Self-citationSenturk, S., Mumcuoglu, M., Gursoy-Yuzugullu, O., Cingoz, B., Akcali, K. C., & Ozturk, M. (2010) · Hepatology · doi:10.1002/hep.23769 · Cited by 238 · cited 1×
“TGFβ, a robust inhibitor of hepatocyte cell cycle progression, has also demonstrated therapeutic potential in managing HCC, triggering cellular senescence in tumour cells and exerting inhibitory effects on tumour growth in murine models 173 .”
Aging and Regional Differences in Fat Cell Progenitors – A Mini-Review
Sepe, A., Tchkonia, T., Thomou, T., Zamboni, M., & Kirkland, J. L. (2011) · Gerontology · doi:10.1159/000279755 · Cited by 232 · cited 1×
“More specifically, lipids get transferred from the subcutaneous adipose tissue to the intra-abdominal visceral depots and other ectopic tissues, including the liver and the muscle, which increases the risk of metabolic diseases 117 .”
Chronic hyperinsulinemia promotes human hepatocyte senescence
Baboota, R. K., Spinelli, R., Erlandsson, M. C., Brandão, B. B., Lino, M., Yang, H., Mardinoğlu, A., Bokarewa, M. I., Boucher, J., Kahn, C. R., et al. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101558 · Cited by 230 · cited 1×
“This process is induced by insulin as inhibiting its signalling pathway protected hepatocytes against senescence 125 .”
Schnabl, B., Purbeck, C. A., Choi, Y. H., Hagedorn, C. H., & Brenner, D. (2003) · Hepatology · doi:10.1053/jhep.2003.50097 · Cited by 224 · cited 1×
“Activated human HSCs that undergo replicative senescence in vitro switch from a fibrogenic to a pro-inflammatory phenotype 91 .”
Ota, H., Eto, M., Kano, M. R., Kahyo, T., Setou, M., Ogawa, S., Iijima, K., Akishita, M., & Ouchi, Y. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.210500 · Cited by 218 · cited 1×
“…hydroxymethylglutaryl-CoA reductase inhibitors and are widely employed for reducing cholesterol levels in patients diagnosed with hypercholesterolaemia, were reported to inhibit oxidative stress derived by endothelial senescence in diabetic mice and in human umbilical vein endothelial cells 155 .”
Neutrophils induce paracrine telomere dysfunction and senescence in ROS‐dependent manner
Lagnado, A., Leslie, J., Ruchaud‐Sparagano, M., Victorelli, S., Hirsova, P., Ogrodnik, M., Collins, A. L., Vizioli, M. G., Habiballa, L., Saretzki, G., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020106048 · Cited by 211 · cited 1×
“A different mechanism that works indirectly is through the recruitment of neutrophils by senescent cells, which in mice promoted ROS production in target cells, also via cell–cell contact, inducing telomere dysfunction and senescence in the liver 109 .”
Li, F., Huangyang, P., Burrows, M., Guo, K., Riscal, R., Godfrey, J., Lee, K. E., Lin, N., Lee, P., Blair, I. A., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-020-0511-2 · Cited by 209 · cited 1×
“This treatment combination showed promising results in limiting HSC SASP and tumour progression in mice driven by FBP1 loss 142 .”
Pseudocapillarization and associated energy limitation in the aged rat liver
Le Couteur, D. (2001) · Hepatology · doi:10.1053/jhep.2001.22754 · Cited by 207 · cited 2×
“Senescence of LSECs leads to pseudocapillarization, reduced endocytic and vasodilatory capacity, decreased plasticity in blood flow, and increased production of mitochondrial oxidative stress 61,62,66,67 .”
Marshall, A., Rushbrook, S., Davies, S. E., Morris, L. S., Scott, I. S., Vowler, S. L., Coleman, N., & Alexander, G. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.09.076 · Cited by 205
Takahashi, A., Imai, Y., Yamakoshi, K., Kuninaka, S., Ohtani, N., Yoshimoto, S., Hori, S., Tachibana, M., Anderton, E., Takeuchi, T., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.10.018 · Cited by 205 · cited 1×
“…the induction of proteasomal degradation of histone methyltransferases, such as G9a and GLP, through the activation of APC/C Cdh1 ubiquitin ligase 28 , the upregulation of LINE-1 elements 29 , and the transcription of stimulator of interferon genes (STING), which promotes the production of SASP…”
Noureddin, M., Yates, K. P., Vaughn, I. A., Neuschwander-Tetri, B. A., Sanyal, A. J., McCullough, A., Merriman, R., Hameed, B., Doo, E., Kleiner, D. E., et al. (2013) · Hepatology · doi:10.1002/hep.26465 · Cited by 196 · cited 2×
“In accordance, older patients also have a higher risk of developing MASH and advanced fibrosis than younger patients 116 .”
Algorithmic assessment of cellular senescence in experimental and clinical specimens
Kohli, J., Wang, B., Brandenburg, S. M., Basisty, N., Evangelou, K., Varela-Eirin, M., Campisi, J., Schilling, B., Gorgoulis, V., & Demaria, M. (2021) · Nature Protocols · doi:10.1038/s41596-021-00505-5 · Cited by 196 · cited 1×
“…which combines SA-β-gal or lipofuscin quantification, followed by co-staining with other known markers of senescence such as p16 or p21, and further validated with specific markers of the particular senescent context 1 , such as SASP molecules of a specific senescent stimulus or cell type 36 .”
Xiang, X., Feng, D., Hwang, S., Ren, T., Wang, X., Trojnar, E., Matyas, C., Mo, R., Shang, D., He, Y., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.11.013 · Cited by 189 · cited 1×
“Differently, induction of IL-22, which has been found to induce senescence of HSCs in mice 98 , might be an effective antifibrotic treatment 174–176 .”
Ageing, telomeres, senescence, and liver injury
Hoare, M., Das, T., & Alexander, G. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.06.009 · Cited by 181 · cited 1×
“Related to this, hepatocytes in the aged liver also show several morphological characteristics, such as diminished volume, accumulation of dense bodies in the cytoplasm, a decline in smooth-surfaced endoplasmic reticulum and its respective enzymes, and an increase in polyploidy 6,42 .”
Senescence in chronic liver disease: Is the future in aging?
Aravinthan, A. D., & Alexander, G. J. M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.030 · Cited by 174 · cited 3×
“Cellular senescence, which emerges as a pivotal molecular mechanism aimed at inhibiting cell replication in response to cellular damage or following a finite number of cell division cycles, might also contribute to the development of liver diseases 2,3 .”
InfluentialEffects of aging on liver microcirculatory function and sinusoidal phenotype
Maeso‐Díaz, R., Ortega‐Ribera, M., Fernández‐Iglesias, A., Hide, D., Muñoz, L., Hessheimer, A. J., Vila, S., Francés, R., Fondevila, C., Albillos, A., et al. (2018) · Aging Cell · doi:10.1111/acel.12829 · Cited by 174 · cited 10×
“In this regard, our group has shown a relevant increased protein and gene expression of HSC activation markers, including Acta2 and platelet-derived growth factor receptor-β, together with inflammatory, pro-oxidant and senescence markers, indicating a partial activation of HSCs during ageing 61 .”
InfluentialSelf-citationSeo, E., Kang, H., Choi, H., Choi, W., & Jun, H. (2019) · Aging Cell · doi:10.1111/acel.12895 · Cited by 173 · cited 4×
“…as observed in mice and HepG2 cells, senescent hepatocytes also have a higher lipid and glucose uptake, with an increased expression of genes involved in cholesterol uptake and synthesis, which might explain the increased susceptibility of older patients to develop metabolic liver disease 38 .”
InfluentialYamagishi, R., Kamachi, F., Nakamura, M., Yamazaki, S., Kamiya, T., Takasugi, M., Cheng, Y., Nonaka, Y., Yukawa-Muto, Y., Thuy, L. T. T., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abl7209 · Cited by 173 · cited 2×
“Additionally, lipoteichoic acid, a cell wall component of gram-positive bacteria, induced the secretion of IL-33 by HSCs and promoted HCC in mice 94 .”
Macrophages in the Aging Liver and Age-Related Liver Disease
Stahl, E. C., Haschak, M. J., Popovic, B., & Brown, B. N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02795 · Cited by 171 · cited 1×
“Although senescent hepatic macrophages have not been extensively studied, research focusing on resident macrophages in other tissues shows evident deregulation of autophagy, phagocytic clearance of substances and antigen presentation capacity 104 .”
Age‐related pseudocapillarization of the human liver
McLean, A. J., Cogger, V. C., Chong, G. C., Warren, A., Markus, A. M., Dahlstrom, J. E., & Le Couteur, D. G. (2003) · The Journal of Pathology · doi:10.1002/path.1328 · Cited by 170 · cited 1×
“LSEC pseudocapillariza-tion has been described in several species, including humans, rats and mice 61,68,69 .”
Age‐related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat†
Hilmer, S. N., Cogger, V. C., Fraser, R., McLean, A. J., Sullivan, D., & Le Couteur, D. G. (2005) · Hepatology · doi:10.1002/hep.20937 · Cited by 148 · cited 1×
“This accumulation poses an increased risk of various age-related diseases, such as the formation of atherosclerosis 81 .”
Friend or foe? The elusive role of hepatic stellate cells in liver cancer
Cogliati, B., Yashaswini, C. N., Wang, S., Sia, D., & Friedman, S. L. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00821-z · Cited by 148 · cited 1×
“Conversely, HSCs lacking functional p53 secrete specific factors that facilitate the polarization of macrophages towards a tumour-promoting phenotype through the secretion of IL-33, therefore enhancing the proliferation of premalignant cells 93–95 .”
Resveratrol ameliorates hepatic metaflammation and inhibits NLRP3 inflammasome activation
Yang, S. J., & Lim, Y. (2014) · Metabolism · doi:10.1016/j.metabol.2014.02.003 · Cited by 146 · cited 1×
“Also, other clinical and preclinical studies have found that resveratrol targets other parameters in the liver that are usually altered due to senescence, such as oxidative stress, mitochondrial dysfunction and lipid accumulation 164–166 .”
Hepatic lipid metabolism and non-alcoholic fatty liver disease in aging
Gong, Z., Tas, E., Yakar, S., & Muzumdar, R. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.12.022 · Cited by 144 · cited 1×
“…in the liver, other alterations associated with age, such as insulin and leptin resistance, the decrease in growth hormone and adiponectin, hypercholesterolaemia, DNA damage, accumulation of ROS and telomere shortening, also contribute to a higher risk of MASLD in the older population 114,115 .”
The role of cellular senescence and SASP in tumour microenvironment
Takasugi, M., Yoshida, Y., Hara, E., & Ohtani, N. (2023) · The FEBS Journal · doi:10.1111/febs.16381 · Cited by 144 · cited 3×
“…the organism prevents tumorigenesis, acting as a barrier against the development and progression of HCC. Senescence inhibits the growth of damaged or malignant cells that could potentially give rise to a tumour, mainly through p16 and p53 activation, arresting the Review article cell cycle 112 .”
InfluentialDuan, J., Ruan, B., Song, P., Fang, Z., Yue, Z., Liu, J., Dou, G., Han, H., & Wang, L. (2022) · Hepatology · doi:10.1002/hep.32209 · Cited by 142 · cited 1×
“Indeed, Duan and colleagues found that, in mice after partial hepatectomy, LSEC senescence induced by shear stress through the Notch signalling pathway interfered with liver regeneration 83 .”
Aging promotes the development of diet-induced murine steatohepatitis but not steatosis
Fontana, L., Zhao, E., Amir, M., Dong, H., Tanaka, K., & Czaja, M. J. (2013) · Hepatology · doi:10.1002/hep.26099 · Cited by 127 · cited 1×
“…diet (HFD) showed an increased inflammatory response in the liver, caused by an increased percentage of pro-inflammatory macrophages and tumour necrosis factor; however, when compared with their younger counterparts, the investigators found no differences in fat accumulation caused by age 121 .”
Aravinthan, A., Pietrosi, G., Hoare, M., Jupp, J., Marshall, A., Verrill, C., Davies, S., Bateman, A., Sheron, N., Allison, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072904 · Cited by 117 · cited 3×
“In a study in patients with ALD, including 77 patients with ALD cirrhosis, a spatial association was found between senescent p21-positive hepatocytes and activated HSCs 44 , supporting the notion that hepatocyte senescence, activation of HSCs and fibrosis are linked.”
Lockart, I., Yeo, M. G. H., Hajarizadeh, B., Dore, G. J., & Danta, M. (2022) · Hepatology · doi:10.1002/hep.32341 · Cited by 115 · cited 1×
“Consequently, these factors contribute to an increased HCC incidence in older patients with cirrhosis following HCV cure, compared with younger ones 185 .”
Basal Activity of Kupffer Cells Increases With Old Age
Hilmer, S. N., Cogger, V. C., & Couteur, D. G. L. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.9.973 · Cited by 113 · cited 2×
“Preclinical studies have found that aged livers exhibit a higher number of Kupffer cells than younger counterparts, accompanied by an increased phagocytic activity 101 and lower levels of autophagy 102 (Box 2).”
Age-related changes in the hepatic microcirculation in mice
Ito, Y., Sørensen, K. K., Bethea, N. W., Svistounov, D., McCuskey, M. K., Smedsrød, B. H., & McCuskey, R. S. (2007) · Experimental Gerontology · doi:10.1016/j.exger.2007.04.008 · Cited by 113 · cited 2×
“Senescence of LSECs leads to pseudocapillarization, reduced endocytic and vasodilatory capacity, decreased plasticity in blood flow, and increased production of mitochondrial oxidative stress 61,62,66,67 .”
Liu, B., Zhou, Z., Jin, Y., Lu, J., Feng, D., Peng, R., Sun, H., Mu, X., Li, C., & Chen, Y. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003069 · Cited by 112 · cited 2×
“These factors contributed to the progression of liver cirrhosis to HCC 135 .”
Jin, J., Iakova, P., Jiang, Y., Medrano, E. E., & Timchenko, N. A. (2011) · Hepatology · doi:10.1002/hep.24471 · Cited by 107 · cited 1×
“This protein is known to be critical in the regulation of ageing; specifically in the liver of old mice, SIRT1 is repressed by the CEBPB–HDAC1 complex, which inhibits its expression, reducing the liver proliferative capabilities 51 .”
Ink4‐Arf locus in cancer and aging
Sherr, C. J. (2012) · WIREs Developmental Biology · doi:10.1002/wdev.40 · Cited by 98
Senescent human hepatocytes express a unique secretory phenotype and promote macrophage migration
Irvine, K. M., Skoien, R., Bokil, N. J., Melino, M., Thomas, G. P., Loo, D., Gabrielli, B., Hill, M. M., Sweet, M. J., Clouston, A. D., et al. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i47.17851 · Cited by 97 · cited 2×
“38 The increased secretion of senescence-associated secretory phenotype (SASP) by senescent hepatocytes recruits pro-inflammatory macrophages and liberates cell proliferation inhibitors, contributing to senescence expansion through the liver environment 49 .”
Emerging role of aging in the progression of NAFLD to HCC
He, Y., Su, Y., Duan, C., Wang, S., He, W., Zhang, Y., An, X., & He, M. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101833 · Cited by 97 · cited 8×
“Clinical studies have shown that MASLD prevalence increases with age 7,181 being 16% higher in older patients than in younger ones, with the former having an increased risk of advanced fibrosis during MASH, among other features of severe damage 116 .”
InfluentialHsp90 inhibitors as senolytic drugs to extend healthy aging
Fuhrmann-Stroissnigg, H., Niedernhofer, L. J., & Robbins, P. D. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1475828 · Cited by 92 · cited 1×
“HSP90 proteins have a crucial role in cellular processes by interacting with co-chaperones to ensure proper folding, stabilization, or, if necessary, degradation of client proteins 148 .”
Qi, X., Song, A., Ma, M., Wang, P., Zhang, X., Lu, C., Zhang, J., Zheng, S., & Jin, H. (2021) · Cell Proliferation · doi:10.1111/cpr.13107 · Cited by 91 · cited 2×
“This mechanism is believed to be induced by the protective effects of curcumol on iron overload, which is upregulated in MASLD and causes ROS accumulation, which induces cell senescence 167 .”
Huang, Y.-H., Chen, M.-H., Guo, Q.-L., Chen, Z.-X., Chen, Q.-D., & Wang, X.-Z. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2019.109445 · Cited by 90 · cited 1×
“The cytokines IL-10 and IL-22 were described in rats and mice, respectively, as senescence inducers in activated HSCs via the STAT3–P53 pathway, ultimately ameliorating liver fibrosis 97,98 .”
Crosstalk between the Rb pathway and AKT signaling forms a quiescence-senescence switch.
Imai, Y., Takahashi, A., Hanyu, A., Hori, S., Sato, S., Naka, K., Hirao, A., Ohtani, N., & Hara, E. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.03.006 · Cited by 84 · cited 2×
“Senescent hepatocytes undergo morphological changes, including a reduction in cellular volume and an increase in nuclear polyploidy 6,52 .”
Aging of Liver in Its Different Diseases
Radonjić, T., Dukić, M., Jovanović, I., Zdravkovic, M. D., Mandić, O., Popadić, V., Popović, M., Nikolić, N., Klašnja, S., Divac, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113085 · Cited by 83 · cited 1×
“…senescent phenotype in cells already committed to it or by inducing senescence in healthy cells through the secretion of various interleukins, a phenomenon known as the bystander effect 105,106 , which might explain, partially, why in the liver, senescent hepatocytes tend to cluster together 59 .”
The role of mitochondria dysfunction and hepatic senescence in NAFLD development and progression
Dabravolski, S. A., Bezsonov, E. E., & Orekhov, A. N. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112041 · Cited by 82 · cited 1×
“…acids in the liver and its consequent upregulation in fatty acid β-oxidation induces a higher generation of ROS in the mitochondria, promoting telomere erosion, direct DNA damage and a decrease in electron transport chain activity, with the latter activating pathways involved in senescence 126 .”
Huang, Y., Yang, X. F., Meng, Y., Shao, C., Liao, J., Li, F., Li, R., Jing, Y., & Huang, A. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00683-5 · Cited by 82 · cited 3×
“However, in preclinical models of advanced HCC, senescence contributes to its progression, altering the tumour microenvironment through SASP 43,138 .”
M2 Kupffer Cells Promote Hepatocyte Senescence
Wan, J., Benkdane, M., Alons, E., Lotersztajn, S., & Pavoine, C. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.02.014 · Cited by 77
Mohamad, M., Mitchell, S. J., Wu, L. E., White, M. Y., Cordwell, S. J., Mach, J., Solon‐Biet, S. M., Boyer, D., Nines, D., Das, A., et al. (2016) · Aging Cell · doi:10.1111/acel.12481 · Cited by 77 · cited 1×
“Loss of fenestrations, which serve as windows for the uptake of chylomicron remnants and insulin, can result in hyperlipidaemia and hepatic insulin resistance in rats 70 .”
Senescence-induced endothelial phenotypes underpin immune-mediated senescence surveillance
Yin, K., Patten, D., Gough, S., de Barros Gonçalves, S., Chan, A., Olan, I., Cassidy, L., Poblocka, M., Zhu, H., Lun, A., et al. (2022) · Genes & Development · doi:10.1101/gad.349585.122 · Cited by 73 · cited 3×
“Soluble factors released by senescent cells stimulate the activity of NF-κB in LSECs, leading to the recruitment of STAT1-activated subset of CD4 + T lymphocytes and subsequently influencing the outcome of senescence surveillance 84 .”
InfluentialSustained telomere length in hepatocytes and cholangiocytes with increasing age in normal liver
Verma, S., Tachtatzis, P., Penrhyn-Lowe, S., Scarpini, C., Jurk, D., Von Zglinicki, T., Coleman, N., & Alexander, G. J. M. (2012) · Hepatology · doi:10.1002/hep.25787 · Cited by 72 · cited 1×
“Supporting this idea, aged-related telomere attrition in human liver donors was shown to be restricted to Kupffer cells and HSCs 86 .”
Hepatic pseudocapillarization in aged mice
Warren, A., Bertolino, P., Cogger, V. C., MCLEAN, A., Fraser, R., & Couteur, D. G. L. (2005) · Experimental Gerontology · doi:10.1016/j.exger.2005.06.012 · Cited by 71 · cited 1×
“LSEC pseudocapillariza-tion has been described in several species, including humans, rats and mice 61,68,69 .”
Mechanical Fingerprint of Senescence in Endothelial Cells
Chala, N., Moimas, S., Giampietro, C., Zhang, X., Zambelli, T., Exarchos, V., Nazari‐Shafti, T. Z., Poulikakos, D., & Ferrari, A. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c00064 · Cited by 71 · cited 1×
“…ability to alter their shape and orientation in response to blood flow, caused by the increased adhesion to the substrate and higher contractibility induced by senescence, which are mechanisms necessary to prevent dangerous endothelium permeability and denudation of the underlying substrate 78 .”
Wong, Y. T., Gruber, J., Jenner, A. M., Ng, M. P.-E., Ruan, R., & Tay, F. E. H. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.12.016 · Cited by 70
Aging and Chronic Liver Disease
Maeso-Díaz, R., & Gracia-Sancho, J. (2020) · Seminars in Liver Disease · doi:10.1055/s-0040-1715446 · Cited by 68 · cited 2×
“Within the context of liver cells, hepatocytes, liver sinusoidal endothelial cells (LSECs), hepatic stellate cells (HSCs) and Kupffer cells are all subjected to different changes in their phenotype due to senescence, caused by either liver damage or age 4 .”
Self-citationSinusoidal endothelial cells of the liver: Fine structure and function in relation to age
Margreet De Leeuw, A., Brouwer, A., & Knook, D. L. (1990) · Journal of Electron Microscopy Technique · doi:10.1002/jemt.1060140304 · Cited by 67
Simon-Santamaria, J., Malovic, I., Warren, A., Oteiza, A., Le Couteur, D., Smedsrød, B., McCourt, P., & Sørensen, K. K. (2010) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glq108 · Cited by 67 · cited 1×
“During ageing, the scavenger functions of LSECs are compromised, as evidenced by a reduction in their endocytic capacity 79,80 .”
Endothelial dysfunction in pathological processes of chronic liver disease during aging
Wan, Y., Li, X., Slevin, E., Harrison, K., Li, T., Zhang, Y., Klaunig, J. E., Wu, C., Shetty, A. K., Dong, X. C., et al. (2021) · The FASEB Journal · doi:10.1096/fj.202101426r · Cited by 67 · cited 1×
“These changes can affect hepatic functions, including steatosis, metabolism, vascular tone and regeneration 82 .”
Duan, J., Liu, J., Ruan, B., Ding, J. H., Fang, Z.-Q., Xu, H., Song, P., Chen, X., Li, Z., Du, W., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00348-z · Cited by 67 · cited 2×
“…from the pericentral region of the liver 76 , has been found to be downregulated during ageing repro-gramed liver endothelial zonation, and the researchers of the study suggested that abrogation of endothelial Kit in mice triggered cellular senescence, which could disturb LSEC homeostasis 71 .”
The senescent hepatocyte gene signature in chronic liver disease
Aravinthan, A., Shannon, N., Heaney, J., Hoare, M., Marshall, A., & Alexander, G. J. M. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.011 · Cited by 65 · cited 1×
“As explained above, dysregulation of crucial genes involved in glucose, lipid and protein metabolism was described in vitro in hepatocyte senescence 132 .”
New aspects of hepatic endothelial cells in physiology and nonalcoholic fatty liver disease
Sun, X., & Harris, E. N. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00062.2020 · Cited by 64 · cited 1×
“It has been suggested that CGAS–STING signalling, a cytoplasmic DNA-sensing pathway in cellular senescence, could be an interesting pathway to promote senescence in hepatic endothelial cells 75 .”
Jin, H., Jia, Y., Yao, Z., Huang, J., Hao, M., Yao, S., Lian, N., Zhang, F., Zhang, C., Chen, X., et al. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.02.006 · Cited by 63 · cited 1×
“In fact, senescent HSCs show an increase in surface expression of natural killer cell-activating ligands, promoting their own elimination by the immune system 96 .”
da Silva, B. D. O., Ramos, L. F., & Moraes, K. C. M. (2017) · Cell Biology International · doi:10.1002/cbin.10790 · Cited by 63 · cited 1×
“IL-1 and IL-6 are the most abundant pro-inflammatory cytokines in the SASP 107 , whereas in the liver, as discussed above in the section ‘Hepatic stellate cells’, IL-22 induced HSC senescence in mice, protecting against fibrosis 98 .”
Aging Influences Hepatic Microvascular Biology and Liver Fibrosis in Advanced Chronic Liver Disease
Maeso-Díaz, R., Ortega-Ribera, M., Lafoz, E., Lozano, J. J., Baiges, A., Francés, R., Albillos, A., Peralta, C., García-Pagán, J. C., Bosch, J., et al. (2019) · Aging and disease · doi:10.14336/ad.2019.0127 · Cited by 63 · cited 4×
“Moreover, during cirrhosis, the HSCs of aged rats showed an increased deposition of extracellular matrix (ECM) compared with younger animals 64 , indicating the importance of age in CLD development (Box 2).”
InfluentialSelf-citationExercise Counters the Age-Related Accumulation of Senescent Cells
Zhang, X., Englund, D. A., Aversa, Z., Jachim, S. K., White, T. A., & LeBrasseur, N. K. (2022) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000302 · Cited by 63
Kennedy, A. L., McBryan, T., Enders, G. H., Johnson, F. B., Zhang, R., & Adams, P. D. (2010) · Cell Division · doi:10.1186/1747-1028-5-16 · Cited by 61 · cited 1×
“…21 ; however, they seem to be cell type-dependent and stimulus-dependent as they are not present in all senescent cells, such as mouse fibroblasts, as opposed to human fibroblasts 22 , or during replicative cellular senescence in human fibroblasts resistant to premature p16 INK4a activation 23 .”
Diehl, A. M., Johns, D. C., Yang, S., Lin, H., Yin, M., Matelis, L. A., & Lawrence, J. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.13.7343 · Cited by 60
Tachtatzis, P. M., Marshall, A., Aravinthan, A., Verma, S., Penrhyn-Lowe, S., Mela, M., Scarpini, C., Davies, S. E., Coleman, N., & Alexander, G. J. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0127511 · Cited by 58 · cited 4×
“liver injury, fibrosis and reduced liver function in patients with these conditions 41,46,128 .”
InfluentialSelective insulin resistance in hepatocyte senescence
Aravinthan, A., Challis, B., Shannon, N., Hoare, M., Heaney, J., & Alexander, G. J. M. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.09.025 · Cited by 58 · cited 1×
“…are subjected to metabolic changes, including higher lipid and glucose uptake, with increased expression of genes involved in cholesterol uptake and synthesis 38 and, at the same time, deregulation of glucose transporter GLUT2 and GLUT4 expression, which causes selective insulin resistance 39 .”
The Effects of Old Age on Hepatic Stellate Cells
Warren, A., Cogger, V. C., Fraser, R., DeLeve, L. D., McCuskey, R. S., & Le Couteur, D. G. (2011) · Current Gerontology and Geriatrics Research · doi:10.1155/2011/439835 · Cited by 55 · cited 1×
“Mouse and rat models of ageing have demonstrated an increment in the number of HSCs, accompanied by intracellular accumulation of lipids 61,88 .”
Prediction of fibrosis progression in chronic viral hepatitis
Wong, G. L. (2014) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2014.20.3.228 · Cited by 54
Liu, P., Tang, Q., Chen, M., Chen, W., Lu, Y., Liu, Z., & He, Z. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.589908 · Cited by 54 · cited 4×
“…p16 cell cycle inhibitors), oxidative damage (as demonstrated by increased levels of reactive oxygen species), metabolic changes (such as the accumulation of senescence-associated β-galactosidase), the presence of senescence-associated heterochromatin foci, and the manifestation of a SASP 1,33–37 .”
InfluentialWijayasiri, P., Astbury, S., Kaye, P., Oakley, F., Alexander, G. J., Kendall, T. J., & Aravinthan, A. D. (2022) · Cells · doi:10.3390/cells11142221 · Cited by 54 · cited 2×
“…senescent hepatocytes accumulate in the liver of patients with chronic liver disease (CLD), and studies have shown that the degree of accumulation is correlated with fibrotic stage 44–46 , increased expression of ACTA2 (also known as ɑ -smooth muscle actin or α-SMA) 47 and activation of HSCs 47 .”
The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer
Gibert‐Ramos, A., Sanfeliu-Redondo, D., Aristu-Zabalza, P., Martínez-Alcocer, A., Gracia‐Sancho, J., Guixé‐Muntet, S., & Fernández‐Iglesias, A. (2021) · Cancers · doi:10.3390/cancers13225719 · Cited by 53
Self-citationImpact of Aging on Liver Cells and Liver Disease: Focus on the Biliary and Vascular Compartments
Baiocchi, L., Glaser, S. S., Francis, H., Kennedy, L. L., Felli, É., Alpini, G. D., & Gracia‐Sancho, J. (2021) · Hepatology Communications · doi:10.1002/hep4.1725 · Cited by 50 · cited 1×
“During ageing, the scavenger functions of LSECs are compromised, as evidenced by a reduction in their endocytic capacity 79,80 .”
Self-citationSenescence mirrors the extent of liver fibrosis in chronic hepatitis C virus infection
Wandrer, F., Han, B., Liebig, S., Schlue, J., Manns, M. P., Schulze‐Osthoff, K., & Bantel, H. (2018) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14802 · Cited by 49 · cited 3×
“liver injury, fibrosis and reduced liver function in patients with these conditions 41,46,128 .”
Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH
Bonnet, L., Alexandersson, I., Baboota, R. K., Kroon, T., Oscarsson, J., Smith, U., & Boucher, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.957616 · Cited by 49 · cited 1×
“More specifically, preclinical studies showed that senescence disturbs glucose and lipid metabolism, inducing mitochondrial dysfunction and ROS, which disrupts fatty acid oxidation, causes the accumulation of lipids in the liver and steatosis, which can further progress into MASH 113,123 .”
Schirdewahn, T., Grabowski, J., Sekyere, S. O., Bremer, B., Wranke, A., Lunemann, S., Schlaphoff, V., Kirschner, J., Hardtke, S., Manns, M. P., et al. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw514 · Cited by 46 · cited 2×
“Additionally, elevated protein levels of the senescence marker CD57 were observed in CD8 + T cells in 49 patients with HDV infection, indicating a potential association between HDV infection and immune cell senescence 129 .”
Cisd2 slows down liver aging and attenuates age‐related metabolic dysfunction in male mice
Huang, Y., Shen, Z., Huang, C., Lin, C., & Tsai, T. (2021) · Aging Cell · doi:10.1111/acel.13523 · Cited by 46 · cited 1×
“However, when Cisd2 , which mediates lifespan in mice, was upregulated, the dysregulation of genes involved in lipid metabolism was attenuated 119 .”
Ma, B., Ju, A., Zhang, S., An, Q., Xu, S., Liu, J., Yu, L., Fu, Y., & Luo, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01437-0 · Cited by 46 · cited 1×
“…of MASLD in HFD-fed mice through the hepatic accumulation of so-called albumosomes — spherical shell-like structures in the cytoplasm formed by prefolding albumin — which can trap prefolding carnitine palmi-toyltransferase 2 thereby maintaining mitochondrial homeostasis from exhaustion 149 .”
Duan, J.-L., Zhou, Z.-Y., Ruan, B., Fang, Z.-Q., Ding, J., Liu, J.-J., Song, P., Xu, H., Xu, C., Yue, Z.-S., et al. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.01.019 · Cited by 45 · cited 1×
“Hepatic C-KIT (also known as CD117), a receptor tyrosine kinase used to discriminate and sort LSECs from the pericentral region of the liver 76 , has been found to be downregulated during ageing repro-gramed liver endothelial zonation, and the researchers of the study suggested that abrogation of…”
Saile, B., Matthes, N., Neubauer, K., Eisenbach, C., El-Armouche, H., Dudás, J., & Ramadori, G. P. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00441.2001 · Cited by 44 · cited 1×
“HSCs seem susceptible to undergoing replicative senescence, as they cannot be maintained in vitro during multiple passages 85 .”
The Effects of Metformin on Age-Related Changes in the Liver Sinusoidal Endothelial Cell
Hunt, N. J., Lockwood, G. P., Kang, S. W. (., Pulpitel, T., Clark, X., Mao, H., McCourt, P. A. G., Cooney, G. J., Wali, J. A., Le Couteur, F. H., et al. (2019) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glz153 · Cited by 44 · cited 1×
“In a preclinical study in young and aged mice, metformin ameliorated the typical changes in LSECs caused by age, including increased cell fenestrations, through upregulation in AMPK1 signalling, endothelial nitric oxide synthase (eNOS) and myosin light chain kinase phosphorylation 154 .”
Hide, D., Warren, A., Fernández‐Iglesias, A., Maeso‐Díaz, R., Peralta, C., Couteur, D. G. L., Bosch, J., Cogger, V. C., & Gracia‐Sancho, J. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz012 · Cited by 44 · cited 1×
“such as ischaemia–reperfusion injury, than that of their younger counterparts 72 .”
Self-citationLuo, X., Bai, Y., He, S., Sun, S., Jiang, X., Yang, Z., Lu, D., Wei, P., Liang, Y., Peng, C., et al. (2021) · Cell Proliferation · doi:10.1111/cpr.12991 · Cited by 42 · cited 1×
“These effects were induced by the upregulation of SIRT1, which modulates cell senescence 163 .”
The extent of liver injury determines hepatocyte fate toward senescence or cancer
Wang, C., Chen, W., Wu, Y., You, P., Zheng, S., Liu, C.-C., Xiang, D., Wang, M., Cai, Y., Zhao, Q., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0622-x · Cited by 41 · cited 5×
“Conversely, in mice, hepatocyte senescence is not activated to the same level during chronic injury, which increases the risk of malignant transformation 43 .”
InfluentialCellular senescence in liver fibrosis: Implications for age-related chronic liver diseases
Udomsinprasert, W., Sobhonslidsuk, A., Jittikoon, J., Honsawek, S., & Chaikledkaew, U. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1992385 · Cited by 40 · cited 1×
“The accumulation of senescent cells within affected tissues substantially affects disease progression by exerting an influence over the microenvironment and disrupting tissue homeostasis 18,26 (Fig.”
Hunt, N. J., Lockwood, G. P., Kang, S. W. S., Westwood, L. J., Limantoro, C., Chrzanowski, W., McCourt, P., Kuncic, Z., Couteur, D. G. L., & Cogger, V. C. (2021) · ACS Nano · doi:10.1021/acsnano.0c09278 · Cited by 39 · cited 1×
“This approach could also be achieved using novel nanoformulations such as quantum dots or nanoparticles that could be administered systemically but would specifically target the desired cell type 178 .”
Cellular senescence and hepatitis B‐related hepatocellular carcinoma: An intriguing link
Karakousis, N. D., Papatheodoridi, A. M., Chatzigeorgiou, A., & Papatheodoridis, G. (2020) · Liver International · doi:10.1111/liv.14659 · Cited by 38 · cited 2×
“Furthermore, current knowledge shows that insufficient clearance of both senescent and precancerous hepatocytes, coupled with compromised immune surveillance due to immunosenescence triggered by chronic HBV infection, can contribute to hepatocarcinogenesis 127 .”
Yu, H., Jiang, X., Dong, F., Zhang, F., Ji, X., Xue, M., Yang, F., Chen, J., Hu, X., & Bao, Z. (2021) · Experimental Cell Research · doi:10.1016/j.yexcr.2021.112689 · Cited by 37 · cited 2×
“Specifically, nuclear factor erythroid 2-related factor 2 has been reported to be a key molecule involved in this process, at least in senescent hepatocytes induced by a high content of free fatty acids 48 .”
Lohr, K., Pachl, F., Gholami, A. M., Geillinger, K. E., Daniel, H., Küster, B., & Klingenspor, M. (2016) · Physiological Reports · doi:10.14814/phy2.12988 · Cited by 36 · cited 1×
“Similarly, aged mice also showed higher fat accumulation in the liver, caused by a decrease in mitochondrial function 118 and modifications in their transcriptomic profile associated with genes involved in steatosis.”
Aging and the Biological Response to Liver Injury
Marzioni, M., Pinto, C., Ninfole, E., Gaggiano, L., Benedetti, A., & Maroni, L. (2020) · Seminars in Liver Disease · doi:10.1055/s-0039-3402033 · Cited by 36
Cellular Senescence in Hepatocellular Carcinoma: The Passenger or the Driver?
Cai, X., Guillot, A., & Liu, H. (2022) · Cells · doi:10.3390/cells12010132 · Cited by 36 · cited 2×
“For instance, during early stages, the senescence of damaged hepatocytes prevents their transformation into malignancies, whereas senescence in HSCs mainly controls and restricts their activated, proliferative and pro-inflammatory state 137 .”
Brunt, E. M., Walsh, S. N., Hayashi, P. H., LaBundy, J., & Di Bisceglie, A. M. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01470.x · Cited by 32 · cited 1×
“These senescent hepatocytes have been observed to be predominantly located in periportal or periseptal areas in human liver samples, in which more cell death and the subsequent regeneration occur 40,41 .”
Grosse, L., & Bulavin, D. V. (2020) · Aging · doi:10.18632/aging.103492 · Cited by 30
Regulatory effects of senescence marker protein 30 on the proliferation of hepatocytes
Ishigami, T., Fujita, T., Simbula, G., Columbano, A., Kikuchi, K., Ishigami, A., Shimosawa, T., Arakawa, Y., & Maruyama, N. (2001) · Pathology International · doi:10.1046/j.1440-1827.2001.01238.x · Cited by 27 · cited 1×
“For instance, SMP30 (also known as regucalcin) is a senescence marker in hepatocytes that suppresses cell proliferation 55 .”
Liver damage and senescence increases in patients developing hepatocellular carcinoma
Rey, S., Quintavalle, C., Burmeister, K., Calabrese, D., Schlageter, M., Quagliata, L., Cathomas, G., Diebold, J., Molinolo, A. A., Heim, M. H., et al. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13717 · Cited by 27 · cited 1×
“In a study assessing the impact of liver inflammation, hepatocytes from 33 patients with HCC exhibited higher protein expression levels of senescence markers, resulting from DNA damage, than hepatocytes from 37 patients with cirrhosis and without HCC 139 .”
Novel treatment of acute and acute‐on‐chronic liver failure: Interleukin‐22
Hwang, S., Hicks, A., Hoo, C.-Z., Kwon, Y. S., Cho, Y. E., Moore, J. K., & Gao, B. (2023) · Liver International · doi:10.1111/liv.15619 · Cited by 27
Yang, X. F., Liang, L., Zong, C., Lai, F., Zhu, P., Liu, Y., Jiang, J., Yang, Y., Gao, L., Ye, F., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6744 · Cited by 26 · cited 2×
“The altered autophagy of aged Kupffer cells is thought to predispose the liver to a higher degree of inflammation after liver injury 102 .”
Senescence explains age- and obesity-related liver steatosis
Ogrodnik, M. B., & Jurk, D. (2017) · Cell Stress · doi:10.15698/cst2017.10.108 · Cited by 24 · cited 2×
“Finally, an increase in hepatocyte fat accumulation in mice was accompanied by an increase in markers of senescence 122 .”
Marongiu, F., Serra, M. P., Sini, M., Angius, F., & Laconi, E. (2014) · Aging · doi:10.18632/aging.100631 · Cited by 21 · cited 1×
“Healthy hepatocytes facilitated the clearance of tumour-promoting senescent hepatocytes, thereby reducing the rate of HCC development 158 .”
Cellular senescence associated immune responses in liver cancer
Greten, T. F., & Eggert, T. (2017) · Hepatic Oncology · doi:10.2217/hep-2017-0011 · Cited by 21 · cited 1×
“Also, reprogramming the SASP through activating or inhibiting particular cytokines is another proposed treatment that could enhance the recruitment of antitumoural immune cells and inhibit the expression of factors that stimulate tumour growth 177 .”
Shi, T., Yang, X., Zhou, H., Xi, J., Sun, J., Ke, Y., Zhang, J., Shao, Y., Jiang, X., Pan, X., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0189856 · Cited by 19 · cited 15×
“Besides the alteration in the balance between fatty acid oxidation and de novo lipogenesis in the liver, other alterations associated with age, such as insulin and leptin resistance, the decrease in growth hormone and adiponectin, hypercholesterolaemia, DNA damage, accumulation of ROS and telomere shortening, also con…”
InfluentialWuestefeld, A., Iakovleva, V., Yap, S. X. L., Ong, A. B. L., Huang, D. Q., Shuen, T. W. H., Toh, H. C., Dan, Y. Y., Zender, L., & Wüestefeld, T. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1477 · Cited by 18 · cited 1×
“Furthermore, although premalignant hepatocytes regularly undergo senescence triggered by DNA damage or activation of oncogenes 54 , the induction of a pro-regenerative environment following liver injury in mice stimulated hepatocyte growth, posing a potential risk for HCC development 140 .”
Yang, Z., Gao, S., Wong, C. C., Liu, W., Chen, H., Shang, H., Wu, Z. Y., Xu, L., Zhang, X., Wong, N., et al. (2023) · The Journal of Pathology · doi:10.1002/path.6065 · Cited by 18 · cited 1×
“Moreover, the apoptotic effects of navitoclax were enhanced synergistically by combining it with either genetic or pharmacological inhibition of TUBB4B , a recently discovered gene involved in cell proliferation and survival, in MASLD-associated HCC 145 .”
Hepatocyte senescence explains conjugated bilirubinaemia in chronic liver failure
Aravinthan, A. D., & Alexander, G. J. M. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.031 · Cited by 17 · cited 1×
“Conversely, increased expression of MRP3 in senescent hepatocytes might serve as a compensatory mechanism, augmenting the transport of conjugated bilirubin into the hepatic sinusoid 133 .”
Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF
Koudelková, P., Weber, G., & Mikulits, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142134 · Cited by 17 · cited 2×
“P16 INK4a and p19 ARF (p14 ARF in humans) proteins have been proposed as regulators of in vitro replicative senescence of LSECs 73,74 .”
Odagiri, N., Matsubara, T., Higuchi, M., Takada, S., Urushima, H., Sato-Matsubara, M., Teranishi, Y., Yoshizato, K., Kawada, N., & Ikeda, K. (2019) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3466-x · Cited by 17 · cited 1×
“Different types of induced senescence in human HSCs have been shown to enhance phosphorylation of ERK1 and ERK2, and to induce expression of ANGPTL4 , Il8 , and PF4V1 genes, which have been associated with the progression of liver disease to HCC 134 .”
Hide, D., Ortega‐Ribera, M., Warren, A., Couteur, D. G. L., Bosch, J., Cogger, V. C., & Gracia‐Sancho, J. (2016) · Journal of Hepatology · doi:10.1016/s0168-8278(16)00419-0 · Cited by 15
Self-citationVats, R., Li, Z., Ju, E.-M., Dubey, R. K., Kaminski, T. W., Watkins, S. C., & Pradhan‐Sundd, T. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00408.2021 · Cited by 14
Navitoclax improves acute‐on‐chronic liver failure by eliminating senescent cells in mice
Watanabe, Y., Abé, H., Kimura, N., Arao, Y., Ishikawa, N., Yuichiro, M., Setsu, T., Sakamaki, A., Kamimura, H., Yokoo, T., et al. (2023) · Hepatology Research · doi:10.1111/hepr.13879 · Cited by 14 · cited 1×
“In a preclinical model of acute liver failure, navitoclax could eliminate senescent cells in vivo, alleviate SASP effects, and improve mitochondrial function 144 .”
Liu, Z. Y., Wang, W., Jin, B., Li, G., Du, G., Zhang, Z. L., Han, L., Huang, G., & Tang, Z. (2014) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.12.071 · Cited by 9 · cited 1×
“Similarly, the improvement in telomerase activity prevented HFD-induced telomere shortening, which ameliorated MASLD 168 , and the exogenous delivery of the human TERT gene into rats before liver transplantation alleviated ischaemia–reperfusion injury, especially in aged livers 169 .”
Liposomal IL-22 ameliorates liver fibrosis through miR-let7a/STAT3 signaling in mice
El-Shorbagy, A. A., Shafaa, M. W., Elbeltagy, R. S., El‐Hennamy, R. E., & Nady, S. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111015 · Cited by 6 · cited 1×
“Differently, induction of IL-22, which has been found to induce senescence of HSCs in mice 98 , might be an effective antifibrotic treatment 174–176 .”
Cited by
Metabolic reprogramming in liver fibrosis
Horn, P., & Tacke, F. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.05.003 · Cited by 432
Metformin decelerates aging clock in male monkeys
Yang, Y., Lu, X., Liu, N., Ma, S., Zhang, H., Zhang, Z., Yang, K., Jiang, M., Zheng, Z., Qiao, Y., et al. (2024) · Cell · doi:10.1016/j.cell.2024.08.021 · Cited by 227
Molecular mechanisms in liver repair and regeneration: from physiology to therapeutics
Ma, X., Huang, T., Chen, X., Li, Q., Liao, M., Fu, L., Huang, J., Yuan, K., Wang, Z., & Zeng, Y. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02104-8 · Cited by 133
Macrophages: Subtypes, Distribution, Polarization, Immunomodulatory Functions, and Therapeutics
Peng, M., Li, N., Wang, H., Li, Y., Liu, H., Luo, Y., Lang, B., Zhang, W., Li, S., Tian, L., et al. (2025) · MedComm · doi:10.1002/mco2.70304 · Cited by 122
Couteur, D. G. L., Ngu, M., Hunt, N. J., Brandon, A. E., Simpson, S. J., & Cogger, V. C. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01099-z · Cited by 89
“Cellular senescence Ageing 19,112,245 Cellular senescence detected in all liver cell types, including hepatocytes HCC 6,246 Senescence is protective against HCC initiation by reducing cellular proliferation Secretion of inflammatory cytokines (SASP) contributes to inflammation in chronic liver…”
Metadata
- Authors
- Sanfeliu-Redondo, D., Gibert-Ramos, A., & Gracia-Sancho, J.
- Affiliations
- Hospital Clínic de Barcelona (ES)
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2024-03-14
- Volume
- 21
- Issue
- 7
- Pages
- 477-492
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W4392817758
- Cited by
- 117
- References
- 187
- Citations by year
- 2026: 65 · 2025: 42 · 2024: 10
- FWCI
- 6.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Reviews Gastroenterology & Hepatology (publishedVersion)
- PubMed (publishedVersion)
- BORIS (University Library Bern) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- cellular senescence, chronic liver disease, hepatocellular carcinoma, senescence-associated secretory phenotype, senolytics, liver disease progression
- MeSH terms
- Aging, Humans, Liver, Liver Diseases, Cellular Senescence, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.